A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Vaccination with meningococcal serogroup C (MenC) conjugate (MCC) polysaccharide vaccines led to a substantial decline in MenC disease in the vaccinated and the unvaccinated population. The decline in the unvaccinated population can be explained by herd protection by reduced colonization of meningococci expressing the MenC capsule. The duration of such herd protection is unknown. METHODS: In a nationwide study from the Netherlands, we compared MenC invasive disease between 1998 and the introduction of MCC vaccination (2002) with that from 2002 to 2012, in age groups eligible and not eligible for vaccination. The proportions of isolates from clonal complexes with high serogroup C capsule expression rate during carriage (sequence type [ST] 11 and ST-8 complex) was compared between the pre- and postvaccination periods. RESULTS: A total of 814 patients with invasive MenC disease were included for analysis. There was a 99% decline in MenC disease in patients eligible for vaccination and a 93% decline in those not eligible. Thirty-six percent of the overall MenC reduction between the first and last 4 years of the observation period occurred in the unvaccinated population. Clonal complex was determined in 350 (43%) isolates. The proportion of cases caused by clonal complex ST-11 and ST-8 serogroup C meningococci decreased from 251 of 268 (94%) before, to 46 of 57 (81%) after MCC vaccine introduction (P = .004). CONCLUSIONS: Our findings provide further evidence that herd protection results from reduced carriage of virulent meningococci. Herd protection was responsible for >36% of MCC vaccine impact and lasted for ≥10 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Self-citationTrotter, C. L., & Maiden, M. C. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.48 · Cited by 203 · cited 4×
“vaccinated population [6, 7].”
BackgroundResultInfluential
Research works printed but not linked: 26
- Trotter, 2007, Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines, FEMS Microbiol Rev, 31, 101, 10.1111/j.1574-6976.2006.00053.x · DOI · Paper page
- de Vries, 2002, Universal vaccination against group C meningococci and pneumococci; advice from the Health Council of the Netherlands, Ned Tijdschr Geneeskd, 146, 1562
- de Greeff, 2006, Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands, Pediatr Infect Dis J, 25, 79, 10.1097/01.inf.0000195594.41449.c6 · DOI · Paper page
- Kaaijk, 2012, Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands, BMC Infect Dis, 12, 35, 10.1186/1471-2334-12-35 · DOI · Paper page
- Maiden, 2008, Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity, J Infect Dis, 197, 737, 10.1086/527401 · DOI · Paper page
- Daugla, 2014, Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected], Lancet, 383, 40, 10.1016/S0140-6736(13)61612-8 · DOI · Paper page
- Campbell, 2010, Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity, Clin Vaccine Immunol, 17, 840, 10.1128/CVI.00529-09 · DOI · Paper page
- de Voer, 2010, Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal C conjugate vaccine, PLoS One, 5, e12144, 10.1371/journal.pone.0012144 · DOI
- Ishola, 2012, Prevalence of serum bactericidal antibody to serogroup C Neisseria meningitidis in England a decade after vaccine introduction, Clin Vaccine Immunol, 19, 1126, 10.1128/CVI.05655-11 · DOI
- Caugant, 2008, Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease, Infect Genet Evol, 8, 558, 10.1016/j.meegid.2008.04.002 · DOI
- Jolley, 2007, Molecular typing of meningococci: recommendations for target choice and nomenclature, FEMS Microbiol Rev, 31, 89, 10.1111/j.1574-6976.2006.00057.x · doi:10.1111/j.1574-6976.2006.00057.x
- Claus, 2005, Genetic analysis of meningococci carried by children and young adults, J Infect Dis, 191, 1263, 10.1086/428590 · DOI · Paper page
- Spanjaard, 1985, The incidence of bacterial meningitis in the Netherlands—a comparison of three registration systems, 1977–1982, J Infect, 11, 259, 10.1016/S0163-4453(85)93327-4 · DOI
- Ouchterlony, 1949, Antigen-antibody reactions in gels, Acta Pathol Microbiol Scand, 26, 507, 10.1111/j.1699-0463.1949.tb00751.x · DOI · Paper page
- Maiden, 1998, Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms, Proc Natl Acad Sci U S A, 95, 3140, 10.1073/pnas.95.6.3140 · DOI · Paper page
- de Greeff, 2003, The first effect of the national vaccination campaign against meningococcal-C disease: a rapid and sharp decrease in the number of patients, Ned Tijdschr Geneeskd, 147, 1132
- Fine, 2011, “Herd immunity”: a rough guide, Clin Infect Dis, 52, 911, 10.1093/cid/cir007 · DOI · Paper page
- Clemens, 2011, New approaches to the assessment of vaccine herd protection in clinical trials, Lancet Infect Dis, 11, 482, 10.1016/S1473-3099(10)70318-2 · DOI
- Miller, 2001, Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story, Vaccine, 20, S58, 10.1016/S0264-410X(01)00299-7 · DOI · Paper page
- Muhlemann, 1997, Can herd immunity influence the assessment of vaccine efficacy in nonrandomized studies?, Am J Public Health, 87, 113, 10.2105/AJPH.87.1.113 · DOI
- Hayes, 2000, Design and analysis issues in cluster-randomized trials of interventions against infectious diseases, Stat Methods Med Res, 9, 95, 10.1191/096228000670953670 · DOI
- Christensen, 2010, Meningococcal carriage by age: a systematic review and meta-analysis, Lancet Infect Dis, 10, 853, 10.1016/S1473-3099(10)70251-6 · DOI · Paper page
- Pollard, 2001, Development of natural immunity to Neisseria meningitidis, Vaccine, 19, 1327, 10.1016/S0264-410X(00)00333-9 · doi:10.1016/s0264-410x(00)00333-9
- Griffin, 2004, Epidemiology of respiratory infections in young children: insights from the new vaccine surveillance network, Pediatr Infect Dis J, 23, S188, 10.1097/01.inf.0000144660.53024.64 · DOI
- Harrison, 2010, Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era—United States, 2000–2005, J Infect Dis, 201, 1208, 10.1086/651505 · DOI
- Bijlsma, 2014, Epidemiology of invasive meningococcal disease from 1960 through 2012: a study of national surveillance data from the Netherlands, Lancet Infect Dis, 10.1016/S1473-3099(14)70806-0 · DOI
Cited by
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.007 · Cited by 919
Self-citationBijlsma, M. W., Brouwer, M. C., Kasanmoentalib, E. S., Kloek, A. T., Lucas, M. J., Tanck, M. W., van der Ende, A., & van de Beek, D. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00430-2 · Cited by 412
Self-citationCommunity-acquired bacterial meningitis
van de Beek, D., Brouwer, M., Hasbun, R., Koedel, U., Whitney, C. G., & Wijdicks, E. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.74 · Cited by 312
Self-citationCommunity-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
Self-citationAcute bacterial meningitis in adults
McGill, F., Heyderman, R. S., Panagiotou, S., Tunkel, A. R., & Solomon, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30654-7 · Cited by 274
Metadata
- Authors
- Bijlsma, M. W., Brouwer, M. C., Spanjaard, L., van de Beek, D., & van der Ende, A.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-07-28
- Volume
- 59
- Issue
- 9
- Pages
- 1216-1221
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2116995839
- Cited by
- 86
- References
- 2
- FWCI
- 9.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination. https://app.cochat.ai/papers/10.1093/cid/ciu601
- The paper
- Bijlsma, M. W., Brouwer, M. C., Spanjaard, L., van de Beek, D., & van der Ende, A. (2014). A Decade of Herd Protection After Introduction of Meningococcal Serogroup C Conjugate Vaccination. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciu601
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.